SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-000307
Filing Date
2021-01-08
Accepted
2021-01-08 16:17:20
Documents
14
Period of Report
2021-01-08
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K xfor-20210108.htm   iXBRL 8-K 35809
  Complete submission text file 0001628280-21-000307.txt   185400

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20210108.xsd EX-101.SCH 2423
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xfor-20210108_cal.xml EX-101.CAL 710
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xfor-20210108_def.xml EX-101.DEF 1643
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20210108_lab.xml EX-101.LAB 25998
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20210108_pre.xml EX-101.PRE 13731
7 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20210108_htm.xml XML 11812
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 21517659
SIC: 2836 Biological Products, (No Diagnostic Substances)